Vincamine ameliorates hepatic fibrosis via inhibiting S100A4‐mediated farnesoid X receptor activation: based on liver microenvironment and enterohepatic circulation dependence
Sign Up to like & getrecommendations! Published in 2025 at "British Journal of Pharmacology"
DOI: 10.1111/bph.17471
Abstract: Vincamine has extensive biological and pharmaceutical activity. We examined the hepatoprotective effects and mechanisms by which vincamine suppresses hepatic fibrosis. read more here.
Keywords: ameliorates hepatic; hepatic fibrosis; fibrosis via; vincamine ... See more keywords